Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf Conversion in New Liver Transplant Recipients
NCT04761731Phase 4Completed
- Sponsor
- Linical
- Start
- Jul 2015
- Primary completion
- Dec 2017
- Modality
- RNA-Targeting Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus in Liver transplant rejection, sponsored by Linical. Primary endpoint: Incidence rate of biopsy confirmed acute rejection at 24 weeks. Started Jul 2015; status: completed.
02
Drugs
tacrolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT04761731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04761731.